Loading...
Loading...
Supports inhibition of enkephalin-degrading enzymes, potentially prolonging endogenous enkephalin signaling.
Livagen’s mechanisms involve peptidase inhibition and epigenetic modulation. The peptide strongly inhibits enkephalin-degrading enzymes (IC50 ≈ 20 μM) in human serum, which may prolong endogenous enkephalin activity. Notably, this occurs without direct opioid receptor binding. In aging cells, Livagen has been shown to induce heterochromatin decondensation and reactivate ribosomal genes.
Typical Dose
0.5-2mg
A 15-amino-acid peptide derived from human gastric juice with potent tissue-healing and anti-inflammatory properties.
Fertility Preservation: Maintains testosterone and spermatogenesis during TRT.
Potential Benefits: Increases in lean body mass, reductions in adipose tissue, improved metabolic parameters.